Padcev

enfortumab vedotin · Seagen Inc. and Astellas Pharma

Drug timelines are a Plus or Pro feature.

35 regulatory and trial events tracked for Padcev, covering 2021-08-24 to 2026-07-29. Get the full timeline:

Most recent: EMA Authorised: Padcev (Enfortumab vedotin) — Astellas Pharma Europe B.V.